Pasqualini J R, Sumida C, Giambiagi N A, Nguyen B L
C.N.R.S. Steroid Hormone Research Unit, Foundation for Hormone Research, Paris, France.
J Steroid Biochem. 1987;27(4-6):883-9. doi: 10.1016/0022-4731(87)90164-6.
The actions and biological responses of anti-estrogens are a function of: the experimental conditions, the parameters, the organ and the animal species considered. Target tissues for estrogens in the guinea-pig during the perinatal period are interesting models to explore the action of anti-estrogens. The summary of the data indicates: (1) In the fetal uterus of guinea-pig in in vivo experiments (after injection to the maternal compartment) tamoxifen acts as a real agonist concerning growth, as a partial agonist concerning the stimulation of the progesterone receptor. (2) In in vitro experiments (in organ culture of fetal uterus or in isolated cells) anti-estrogens (tamoxifen or 4-hydroxy-tamoxifen) act as antagonists and also inhibit the effects provoked by estrogens. (3) In the uterus and vagina of newborn guinea-pigs, tamoxifen and its derivatives: 4-hydroxytamoxifen and N-desmethyltamoxifen act as real agonists concerning the uterotrophic and vaginotrophic effects, and also stimulate the amount of DNA per organ, but concerning the progesterone receptor in the uterus, in the short treatment anti-estrogens act as partial agonists but they have no effect in the long treatment. In the vagina in the short treatment anti-estrogens provoke no significant effects, but in the long treatment they are full agonists. In neither of the two biological responses studied (growth and progesterone receptor) does tamoxifen and its derivatives block the action of estradiol. (4) The use of a monoclonal antibody to the estrogen receptor revealed quantitative differences in the activation of the estrogen receptor when bound to estradiol or tamoxifen. This observation was in agreement with the lesser extent of binding to DNA-cellulose of the tamoxifen-estrogen receptor complex as compared with the estradiol-estrogen receptor complex. This fact suggests an impaired activation of the estrogen receptor induced by tamoxifen which might be related to the different biological responses provoked by estrogens and anti-estrogens.
实验条件、参数、所考虑的器官和动物物种。豚鼠围产期雌激素的靶组织是探索抗雌激素作用的有趣模型。数据总结表明:(1)在体内实验(注射到母体)中,豚鼠胎儿子宫内的他莫昔芬在生长方面表现为真正的激动剂,在刺激孕酮受体方面表现为部分激动剂。(2)在体外实验(胎儿子宫器官培养或分离细胞)中,抗雌激素(他莫昔芬或4-羟基他莫昔芬)表现为拮抗剂,也抑制雌激素引起的效应。(3)在新生豚鼠的子宫和阴道中,他莫昔芬及其衍生物:4-羟基他莫昔芬和N-去甲基他莫昔芬在子宫营养和阴道营养作用方面表现为真正的激动剂,还刺激每个器官的DNA量,但在子宫中关于孕酮受体,短期治疗时抗雌激素表现为部分激动剂,但长期治疗时无作用。在阴道中,短期治疗时抗雌激素无显著作用,但长期治疗时它们是完全激动剂。在所研究的两种生物学反应(生长和孕酮受体)中,他莫昔芬及其衍生物均未阻断雌二醇的作用。(4)使用雌激素受体单克隆抗体揭示了与雌二醇或他莫昔芬结合时雌激素受体激活的定量差异。这一观察结果与他莫昔芬-雌激素受体复合物与DNA-纤维素的结合程度低于雌二醇-雌激素受体复合物一致。这一事实表明他莫昔芬诱导的雌激素受体激活受损,这可能与雌激素和抗雌激素引起的不同生物学反应有关。